[go: up one dir, main page]

MXPA03004850A - Derivados de piperazina 1,4-disustituida utiles como bloqueadores de alfa1 adrenoceptores uro-selectivos. - Google Patents

Derivados de piperazina 1,4-disustituida utiles como bloqueadores de alfa1 adrenoceptores uro-selectivos.

Info

Publication number
MXPA03004850A
MXPA03004850A MXPA03004850A MXPA03004850A MXPA03004850A MX PA03004850 A MXPA03004850 A MX PA03004850A MX PA03004850 A MXPA03004850 A MX PA03004850A MX PA03004850 A MXPA03004850 A MX PA03004850A MX PA03004850 A MXPA03004850 A MX PA03004850A
Authority
MX
Mexico
Prior art keywords
uro
selective
derivatives useful
piperazine derivatives
adrenoceptor blockers
Prior art date
Application number
MXPA03004850A
Other languages
English (en)
Inventor
Nitya Anand
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Publication of MXPA03004850A publication Critical patent/MXPA03004850A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
MXPA03004850A 2000-11-30 2001-11-29 Derivados de piperazina 1,4-disustituida utiles como bloqueadores de alfa1 adrenoceptores uro-selectivos. MXPA03004850A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1097DE2000 2000-11-30
PCT/IB2001/002261 WO2002044151A1 (en) 2000-11-30 2001-11-29 1,4-disubstituted piperazine derivatives useful as uro-selective $g(a)1-adrenoceptor blockers

Publications (1)

Publication Number Publication Date
MXPA03004850A true MXPA03004850A (es) 2004-01-26

Family

ID=11097130

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03004850A MXPA03004850A (es) 2000-11-30 2001-11-29 Derivados de piperazina 1,4-disustituida utiles como bloqueadores de alfa1 adrenoceptores uro-selectivos.

Country Status (25)

Country Link
US (1) US6914064B2 (es)
EP (1) EP1339682A1 (es)
JP (1) JP2004514711A (es)
KR (1) KR20030068164A (es)
CN (1) CN1230423C (es)
AP (1) AP2003002810A0 (es)
AR (1) AR035930A1 (es)
AU (2) AU2002222315B2 (es)
BG (1) BG107943A (es)
BR (1) BR0115865A (es)
CA (1) CA2430343A1 (es)
CZ (1) CZ20031698A3 (es)
DO (1) DOP2001000296A (es)
EA (1) EA006941B1 (es)
EE (1) EE200300250A (es)
HU (1) HUP0400545A3 (es)
MA (1) MA26064A1 (es)
MX (1) MXPA03004850A (es)
NZ (1) NZ526226A (es)
OA (1) OA12537A (es)
PA (1) PA8534001A1 (es)
PL (1) PL362210A1 (es)
SK (1) SK8052003A3 (es)
WO (1) WO2002044151A1 (es)
ZA (1) ZA200304242B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481888A1 (en) * 2002-04-08 2003-10-16 Ranbaxy Laboratories Limited Alpha, omega-dicarboximide derivatives as useful uro-selective a1a adrenoceptor blockers
WO2005037281A1 (en) * 2003-10-15 2005-04-28 Ranbaxy Laboratories Limited 1-alkylpiperazinyl-pyrrolidin-2, 5-dione derivatives as adrenergic receptor antagonist
WO2005092341A1 (en) * 2004-03-22 2005-10-06 Ranbaxy Laboratories Limited Combination therapy for lower urinary tract symptoms
WO2005113498A1 (en) * 2004-05-19 2005-12-01 Ranbaxy Laboratories Limited Adrenergic receptor antagonists
EP1758583A2 (en) * 2004-05-31 2007-03-07 Ranbaxy Laboratories Limited Arylpiperazine derivatives useful as adrenergic receptor antagonists
WO2006018815A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Piperazine derivatives as adrenergic receptor antagonists
WO2006051374A2 (en) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Arylpiperazines useful as adrenergic receptor antagonists
WO2006051399A1 (en) * 2004-11-11 2006-05-18 Ranbaxy Laboratories Limited Piperazine derivatives useful as adrenergic receptor antagonists
WO2006092710A1 (en) * 2005-03-02 2006-09-08 Ranbaxy Laboratories Limited Metabolites of 2-{3-[4-(2-isopropoxyphenyl) piperazin-1-yl]-propyl}-3a,4,7,7a-tetrahydro-1h-isoindole-1,3-(2h)-dione
WO2006117760A1 (en) * 2005-05-03 2006-11-09 Ranbaxy Laboratories Limited Adrenergic receptor antagonists
WO2007029156A2 (en) * 2005-09-05 2007-03-15 Ranbaxy Laboratories Limited Isoindoledione derivatives as adrenergic receptor antagonists
WO2007039809A1 (en) * 2005-10-05 2007-04-12 Ranbaxy Laboratories Limited Metabolites of 2- {3-[4-(5-fluoro-2-isopropoxy-phenyl)-piperazin-1-yl]-propyl} -5,6-dihydroxy-hexahydro-isoindole-1,3-dione
US9227944B2 (en) 2008-10-10 2016-01-05 Institute Of Pharmacology And Toxicology Academy Of Military Science P.L.A. China Dopamine D3 receptor ligands and preparation and medical uses of the same
JP5701213B2 (ja) 2008-10-10 2015-04-15 インスティチュート オブ ファーマコロジー アンド トキシコロジー アカデミー オブ ミリタリー メディカル サイエンシズ ピー．エル．エー．チャイナ 新規なドーパミンｄ３受容体リガンド、その調製及び使用
NZ711583A (en) 2009-05-05 2017-03-31 Arbutus Biopharma Corp Lipid compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57197265A (en) * 1981-05-29 1982-12-03 Eisai Co Ltd Carboxylic acid imide derivative, its preparation and medicament containing the same
JPS5936661A (ja) * 1982-08-26 1984-02-28 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法ならびにそれを含有する医薬
JPS5976059A (ja) * 1982-10-21 1984-04-28 Sumitomo Chem Co Ltd 環状イミド誘導体及びその酸付加塩
JPS5995267A (ja) * 1982-11-25 1984-06-01 Eisai Co Ltd カルボン酸イミド誘導体およびその製造方法
US4524206A (en) * 1983-09-12 1985-06-18 Mead Johnson & Company 1-Heteroaryl-4-(2,5-pyrrolidinedion-1-yl)alkyl)piperazine derivatives
AT387773B (de) * 1983-09-12 1989-03-10 Bristol Myers Co Verfahren zur herstellung von 1-heteroaryl-4-((2,5-pyrrolidindion-1-yl)aklyl) iperazin-derivaten
JPS60204784A (ja) 1984-03-29 1985-10-16 Eisai Co Ltd カルボン酸イミド誘導体
JP2918899B2 (ja) 1989-03-09 1999-07-12 住友製薬株式会社 環状イミド誘導体の製造方法
US5688795A (en) * 1994-11-08 1997-11-18 Syntex (U.S.A.) Inc. 3-(4-phenylpiperazin-1-yl)propyl-amino, thio and oxy!-pyridine, pyrimidine and benzene derivatives as α1 -adrenoceptor antagonists
ATE201016T1 (de) * 1995-06-09 2001-05-15 Hoffmann La Roche Pyrimidindion-, pyrimidintrion-, triazindion- derivate als alpha-1-adrenergische rezeptorantagonisten
WO1998037893A1 (en) 1997-02-26 1998-09-03 Sumitomo Pharmaceuticals Co., Ltd. Dopamine d4 receptor antagonist
ATE250033T1 (de) * 1997-05-12 2003-10-15 Ortho Mcneil Pharm Inc Arylsubstituierte piperazine die bei der behandlung von gutartiger prostatischer hyperlasie nützlich sind
US6083950A (en) * 1997-11-13 2000-07-04 Ranbaxy Laboratories Limited 1-(4-arylpiperazin-1-yl)-ω-[n-(α,ω-dicarboximido)]-alka nes useful as uro-selective α1-adrenoceptor blockers

Also Published As

Publication number Publication date
MA26064A1 (fr) 2004-04-01
US20020156085A1 (en) 2002-10-24
NZ526226A (en) 2004-05-28
PA8534001A1 (es) 2002-12-11
WO2002044151A1 (en) 2002-06-06
US6914064B2 (en) 2005-07-05
AU2231502A (en) 2002-06-11
PL362210A1 (en) 2004-10-18
CZ20031698A3 (cs) 2003-11-12
OA12537A (en) 2006-06-05
EP1339682A1 (en) 2003-09-03
BR0115865A (pt) 2003-12-23
HUP0400545A2 (hu) 2004-07-28
CN1486300A (zh) 2004-03-31
DOP2001000296A (es) 2003-03-15
EA200300620A1 (ru) 2003-12-25
KR20030068164A (ko) 2003-08-19
BG107943A (bg) 2004-08-31
AU2002222315B2 (en) 2007-06-21
EE200300250A (et) 2003-10-15
AR035930A1 (es) 2004-07-28
CN1230423C (zh) 2005-12-07
HUP0400545A3 (en) 2007-05-02
JP2004514711A (ja) 2004-05-20
ZA200304242B (en) 2004-03-02
EA006941B1 (ru) 2006-06-30
AP2003002810A0 (en) 2003-06-30
CA2430343A1 (en) 2002-06-06
SK8052003A3 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
ZA200207827B (en) Novel piperazine derivatives.
MXPA03005270A (es) Derivados de piperazina.
PL370041A1 (en) 2,4-disubstituted pyrimidinyl derivatives for use as anticancer agents
DE60136530D1 (de) 2,4-disubstituierte thiazolyl derivate
ZA200206198B (en) New aza-indolyl derivatives.
AU4787301A (en) 26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
ZA200107496B (en) Amine derivatives as protease inhitors.
MXPA03004850A (es) Derivados de piperazina 1,4-disustituida utiles como bloqueadores de alfa1 adrenoceptores uro-selectivos.
PL355946A1 (en) 2,4-diaminopyrimidine compounds usful as immunosuppressants
MXPA03008338A (es) Derivados de piperazina.
IL154467A0 (en) 1,4-disubstituted benzenes as insecticides
IL154912A0 (en) Bridged piperazine derivatives
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
ZA200206151B (en) Substituted amionomethyl-phenyl-cyclohexane derivatives.
MXPA03002737A (es) Derivados sustituidos de 1-aminobutan-3-ol.
MXPA03001783A (es) N-(3,5-dicloro-2-metoxifenil)-4-metoxi-3- piperazin-1 -il -bencenosulfonamida.
ZA200100440B (en) Arylpiperazine derivatives useful as uroselective alpha1-adrenoceptor blockers.
IL143024A0 (en) 2,4-disubstituted triazine derivatives
MXPA03002734A (es) Derivados de 5-amino-1-penten-3-ol sustituidos.
NO20015397D0 (no) 1,5-Benzodiazepin-derivater
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
PT1497256E (pt) Compostos de 1,5-diaminopentan-3-ol substituídos
GB0012376D0 (en) 3,4,5-tricyanophenyl derivatives
ITVR20000063A0 (it) Macchina utensile.
IL151782A0 (en) 19-NOR-17alpha-PREGNA-1,3,5(10)-TRIEN-17beta-OLS OF A 21, 16alpha-LACTONE RING